PA500425: Managing polypharmacy and multimorbidity
[Page last updated: 03 August 2022]
| Academic Year: | 2022/23 |
| Owning Department/School: | Department of Pharmacy & Pharmacology |
| Credits: | 15 CATS credits |
| Notional Study Hours: | 150 |
| Level: | FHEQ level 7 |
| Period: |
|
| Assessment Summary: | CW 25%, PF 75% |
| Assessment Detail: |
|
| Supplementary Assessment: |
|
| Requisites: | |
| Learning Outcomes: | * Explain the different types of adverse drug reactions and drug interactions and apply this knowledge to minimise risks associated with polypharmacy. * Discuss the co-morbidities, patient factors and drugs likely to increase the risk of adverse drug reactions and how to minimise these risks through appropriate monitoring or review. * Critically evaluate the currently available screening tools and resources for managing the risks associated with polypharmacy. * Demonstrate a systematic approach to medication reviews of patients with multiple co-morbidities and polypharmacy. * Demonstrate good communication and patient centred consultation skills to approach the ethical decisions regarding de-prescribing, engaging the patient in shared decision-making about their health. * Identify times of high risk in patient care and apply clinical reasoning, professional judgement and leadership within the multidisciplinary team to improve patient outcomes. |
| Aims: | To update knowledge on polypharmacy and multimorbidity and reduce associated risks such as adverse drug reactions.
To appraise the tools available to manage polypharmacy to reduce risk and adverse outcomes such as avoidable hospital admissions. Develop consultation skills to consider the ethical challenges of de-prescribing. To enable pharmacists to apply medicinesoptimisationto support patients on multiple medicines. |
| Skills: | Study skills
Basic clinical examination skills Consultation skills Communication skills Written communication Problem solving Working with others Handling information Leadership skills - influencing skills, challenging inappropriate prescribing Planning and organisation Improving learning and performance Scientific and practical skills Reflective practice Information & communication technology |
| Content: | * Defining polypharmacy and multimorbidity * Adverse drug reactions and interactions * Reducing hospital admissions * Identification of high risk patients and high risk drugs - multiple co-morbidities * Falls risk * Tools for managing polypharmacy * De-prescribing - difficult discussions and ethical decisions * Transfer of Care - a high risk time * Pharmacy services to support medicines optimisation in polypharmacy - medicines review and medicines reconciliation * Evidence-based polypharmacy * Managing care home medicines optimisation * Communication challenges * Care plans. |
| Programme availability: |
PA500425 is Optional on the following programmes:Department of Pharmacy & Pharmacology
|
Notes:
|